NCT05881837: A Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes
- State
- Completed
- Phase
- Phase 2
- People
- 249 taking part
- Started
- 13 Jun 2023
- Primary completion
- 13 Oct 2024
- Arms
- Treatment group A, Treatment group B, Treatment group C, Treatment group D
- Results
- None posted
- 31 May 2023: Trial registered
- 13 Jun 2023: Trial started
- 13 Oct 2024: Trial completed